Clearbridge's device can detect CTCs without antibodies

06/5/2013 | MedGadget.com

Clearbridge BioMedics has introduced the ClearCell FX technology, which can detect circulating tumor cells without the need for antibodies or other labeling techniques, this article says. The system, co-developed with Cambridge Consultants, incorporates a tiny device called the CTChip FR that employs fluid dynamics to isolate CTCs from other cells in blood for further analysis.

View Full Article in:

MedGadget.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA